Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies - Couverture souple

9783030930257: Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies

Couverture souple

ISBN 10 : 3030930254 ISBN 13 : 9783030930257

Editeur : Springer, 2023

Afficher les exemplaires de cette �dition comportant l?ISBN

The book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and development (R&D) of cell and gene therapies.

Les informations fournies dans la section � Synopsis � peuvent faire r�f�rence � une autre �dition de ce titre.

� propos de l?auteur

Hans-Georg Dederer is a full professor and holder of the Chair of Constitutional and Administrative Law, Public International Law, European and International Economic Law at the University of Passau (Germany). His fields of research include biotechnology law. He is also a member of the Permanent Senate Commission on Genetic Research of the German Research Foundation (Deutsche Forschungsgemeinschaft - DFG).

Gregor Frenken is a teaching and research assistant in the Chair of Constitutional and Administrative Law, Public International Law, European and International Economic Law at the University of Passau (Germany).

Les informations fournies dans la section � A propos du livre � peuvent faire r�f�rence � une autre �dition de ce titre.

�diteur: Springer
Date d'�dition: 2023
Langue: anglais
ISBN 10: 3030930254
ISBN 13: 9783030930257
Reliure: Broch�
Nombre de pages: 344
�diteur: Dederer Hans-Georg, Frenken Gregor
Coordonn�es du fabricant: ProductSafety@springernature.com
ProductSafety@springernature.com

Poststr. 9
Darmstadt
64293
Allemagne

Autres �ditions populaires du m�me titre

9783030930226: Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies

Edition pr�sent�e

ISBN 10 : 303093022X ISBN 13 : 9783030930226
Editeur : Springer Nature Switzerland AG, 2022
Couverture rigide

R�sultats de recherche pour Regulation of Genome Editing in Human iPS Cells: A...

Image d'archives

Regulation of Genome Editing in Human iPS Cells (eng)

Dederer, Hans-Georg

Edit� par Springer, 2023

ISBN 10 : 3030930254 ISBN 13 : 9783030930257

Neuf Couverture souple

impression � la demande

Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie

�valuation du vendeur 3 sur 5 �toiles

Etat : new. Questo � un articolo print on demand. N� de r�f. du vendeur GXT5TBC1ZL

Contacter le vendeur

Acheter neuf

EUR 134,27

Exp�dition �EUR 6,80
Exp�dition depuis Italie vers Etats-Unis

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image d'archives

Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies

Edit� par Springer, 2023

ISBN 10 : 3030930254 ISBN 13 : 9783030930257

Neuf Couverture souple

Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni

�valuation du vendeur 5 sur 5 �toiles

Etat : New. In. N� de r�f. du vendeur ria9783030930257_new

Contacter le vendeur

Acheter neuf

EUR 152,36

Exp�dition �EUR 13,89
Exp�dition depuis Royaume-Uni vers Etats-Unis

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Regulation of Genome Editing in Human iPS Cells

Edit� par Springer, Berlin|Springer International Publishing|Springer, 2023

ISBN 10 : 3030930254 ISBN 13 : 9783030930257

Neuf Kartoniert / Broschiert

impression � la demande

Vendeur : moluna, Greven, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Kartoniert / Broschiert. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and development (R&D) of cell and gene therapies. Developments in genome editing are expected to lead to new possibili. N� de r�f. du vendeur 864557070

Contacter le vendeur

Acheter neuf

EUR 144,94

Exp�dition �EUR 48,99
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : Plus de 20 disponibles

Ajouter au panier

Image fournie par le vendeur

Regulation of Genome Editing in Human iPS Cells

Gregor Frenken

Edit� par Springer International Publishing, Springer Nature Switzerland Mai 2023, 2023

ISBN 10 : 3030930254 ISBN 13 : 9783030930257

Neuf Taschenbuch

impression � la demande

Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and development (R&D) of cell and gene therapies. Developments in genome editing are expected to lead to new possibilities for the treatment of hereditary diseases in humans. The treatment of such often severe but hitherto uncurable diseases can be based on genome-edited induced pluripotent stem cells (iPS cells). Such treatments constitute combined cell/gene therapies. These therapies need to be governed by a regulatory framework which ensures quality, safety, and efficacy of the relevant therapeutic products. On the other hand, such regulations may retard product approval and impede R&D. Accordingly, national regulations for therapies based on genome-edited iPS cells are an important and, as the case may be, decisive factor for both researchers and industry regarding their decision where to locate their R&D activities. Therefore, regulatory frameworks impact significantly on the competitiveness of states and their economies. This is why a comparative analysis of laws and regulations of different countries matters. Such a comparative legal analysis provides an important insight into regulatory concepts which, in turn, may inspire adjustments of, or amendments to, domestic legal regimes. For this purpose, experts present country reports on France, Germany, Japan, South Korea, Switzerland, and the USA. The reports on France and Germany also refer to the parameters and implications arising from pertinent EU law. This contributed volume is aimed at researchers, but also at, e.g., legal scholars, lawmakers, regulators, and political decision makers. 344 pp. Englisch. N� de r�f. du vendeur 9783030930257

Contacter le vendeur

Acheter neuf

EUR 171,19

Exp�dition �EUR 23
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 2 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Regulation of Genome Editing in Human iPS Cells | A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies

Hans-Georg Dederer (u. a.)

Edit� par Springer, 2023

ISBN 10 : 3030930254 ISBN 13 : 9783030930257

Neuf Taschenbuch

Vendeur : preigu, Osnabr�ck, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Contacter le vendeur

Acheter neuf

EUR 149

Exp�dition �EUR 70
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 5 disponible(s)

Ajouter au panier

Image d'archives

Regulation of Genome Editing in Human iPS Cells: A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies

Edit� par Springer, 2023

ISBN 10 : 3030930254 ISBN 13 : 9783030930257

Neuf Couverture souple

Vendeur : Books Puddle, New York, NY, Etats-Unis

�valuation du vendeur 4 sur 5 �toiles

Etat : New. N� de r�f. du vendeur 26396414440

Contacter le vendeur

Acheter neuf

EUR 223,75

Exp�dition �EUR 3,46
Exp�dition nationale�: Etats-Unis

Quantit� disponible : 4 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Regulation of Genome Editing in Human iPS Cells

Hans-Georg Dederer

Edit� par Springer, Springer Mai 2023, 2023

ISBN 10 : 3030930254 ISBN 13 : 9783030930257

Neuf Taschenbuch

impression � la demande

Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Introduction.- Biological Aspects of Genome Editing in iPS Cells.- Ethical Aspects in the Context of Genome Editing.- Regulation of Genome Editing in iPS Cells: Germany.- Regulation of Genome Editing in iPS Cells: France.- Regulation of Genome Editing in iPS Cells: Switzerland.- Regulation of Genome Editing in iPS Cells: United States.- Regulation of Genome Editing in iPS Cells: Japan.- Regulation of Genome Editing in iPS Cells: Republic of Korea.- Comparative Analysis.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 344 pp. Englisch. N� de r�f. du vendeur 9783030930257

Contacter le vendeur

Acheter neuf

EUR 171,19

Exp�dition �EUR 60
Exp�dition depuis Allemagne vers Etats-Unis

Quantit� disponible : 1 disponible(s)

Ajouter au panier

Image fournie par le vendeur

Regulation of Genome Editing in Human iPS Cells : A Comparative Legal Analysis of National Regulatory Frameworks for iPSC-based Cell/Gene Therapies

Gregor Frenken

Edit� par Springer International Publishing, Springer Nature Switzerland, 2023

ISBN 10 : 3030930254 ISBN 13 : 9783030930257

Neuf Taschenbuch

Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne

�valuation du vendeur 5 sur 5 �toiles

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The book provides a concise overview of currently applicable regulatory frameworks of states which are among the world leaders in research and development (R&D) of cell and gene therapies. Developments in genome editing are expected to lead to new possibilities for the treatment of hereditary diseases in humans. The treatment of such often severe but hitherto uncurable diseases can be based on genome-edited induced pluripotent stem cells (iPS cells). Such treatments constitute combined cell/gene therapies. These therapies need to be governed by a regulatory framework which ensures quality, safety, and efficacy of the relevant therapeutic products. On the other hand, such regulations may retard product approval and impede R&D. Accordingly, national regulations for therapies based on genome-edited iPS cells are an important and, as the case may be, decisive factor for both researchers and industry regarding their decision where to locate their R&D activities. Therefore, regulatory frameworks impact significantly on the competitiveness of states and their economies. This is why a comparative analysis of laws and regulations of different countries matters. Such a comparative legal analysis provides an important insight into regulatory concepts which, in turn, may inspire adjustments of, or amendments to, domestic legal regimes. For this purpose, experts present country reports on France, Germany, Japan, South Korea, Switzerland, and the USA. The reports on France and Germany also refer to the parameters and implications arising from pertinent EU law. This contributed volume is aimed at researchers, but also at, e.g., legal scholars, lawmakers, regulators, and political decision makers. N� de r�f. du vendeur 9783030930257

Contacter le vendeur